Rubin Lab

RUBIN’S REFLECTIONS

Follow on Twitter @IBDMD

Message to Dr. Rubin’s Patients Related to COVID-19 Boosters

Dear Friends and Patients, I hope this message finds you well. Please excuse the group nature of this message, but I did want to reach out with the latest update about COVID-19, and vaccinations. If you want to skip right to the booster info, scroll down to #5 below....

Tweetorial to Provide Updates on COVID-19 for Patients with IBD

View Twitter Thread To watch me deliver the full lecture and view the presentation, click here. I recently gave a lecture about COVID-19 and vaccination with specific information for patients with IBD. This lecture was recorded on July 21st, before the CDC issued...

SARS Vaccine and IBD Tweetorial Summary from December 1

SARS Vaccine and IBD Tweetorial Summary from December 1 David T. Rubin View Twitter Thread Here are my thoughts and a few updates about SARS-CoV-2 vaccines, and also about important implications for our IBD patients. Development of multiple SARS-CoV-2 vaccines in the...

Three waves of Illness from the COVID-19 Pandemic

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine I've been thinking about what comes next, and how can we get ahead of this, and propose the following for consideration. I believe that there will be three waves of illness from the...

Definition of “healing” and sustained remission

The FDA and others have been interested in the role of histology for assessing “deeper” levels of disease control, with the premise that biopsy may reflect the state of the disease more accurately and perhaps more objectively than endoscopy, and certainly more than...

Dr. David T. Rubin Summarizes His Presentation from Digestive Diseases Week on Advancing Therapies and the Field of IBD

Click here to listen to Dr. Rubin discuss the importance of head-to-head and comparative trials, combination therapies, optimization with timing, escalation and de-escalation, and how we should approach new therapies.

Pregnancy in the Setting of the SARS-CoV-2 Pandemic

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine Dear Colleagues, A lot of concern has recently come up regarding pregnancy in the setting of the SARS-CoV-2 pandemic. Here are some key points I found on this issue: Pregnancy is a state of...

VIDEO: Social media has been a ‘life saver’ during COVID-19 pandemic

Watch this video exclusive, to hear David T. Rubin, MD highlight how the COVID-19 pandemic changed the use of social media.

Message to Dr. Rubin’s Patients Related to COVID-19 Boosters

Dear Friends and Patients, I hope this message finds you well. Please excuse the group nature of this message, but I did want to reach out with the latest update about COVID-19, and vaccinations. If you want to skip right to the booster info, scroll down to #5 below....

IBD As We Age: Thoughts on Treatment and Management For Age 40 and Beyond

There is a growing number of people diagnosed with IBD who are defined as “elderly”. This varies in definition but can be considered those who have IBD older than 50 or older than 60 or 65. I prefer the World Health Organization definition of >65. The two different...

Dr. David T. Rubin Reviews His Presentation from the American College of Gastroenterology Scientific Meeting on Therapeutic Drug Monitoring in IBD

Click here for the full video of Dr. Rubin reviewing his presentation from the American College of Gastroenterology Scientific Meeting on therapeutic drug monitoring (TDM), including the appropriate application of proactive TDM in the treatment of inflammatory bowel...

What Can We Do To Prevent COVID-19?

Click here for the full video discussing the use of COVID-19 vaccines to prevent COVID-19 infections in patients with inflammatory bowel disease.

Dr. Rubin Taps in on “IBD Community Throwing Elbows Over Value of TDM” in Gastroenterology and Endoscopy News

Dr. Mark Silverberg, Dr. David T Rubin, Dr. Laura Targownik, and Dr. Charabaty excitingly discuss why IBD specialists are divided on the topic of therapeutic drug monitoring (TDM). “If the drug is going to work but isn’t present in the body, it doesn’t do its job,”...

Runner’s World Features Fitbit Presentation

Philip Sossenheimer presented our work on wearable devices predicting disease activity in patients with IBD at Digestive Diseases Week 2019. Our study was featured in an article by Elizabeth Millard in Runner’s World titled, “Can Your Fitbit Tell You When a Common...